Company Search:
Advanced Search
Sponsored Links
BB Biotech AG Company Snapshot
BB Biotech AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares BB Biotech AG with three other miscellaneous service companies in Europe: Pharma Mar SA of Spain (2015 sales of 193.82 million Euro [US$205.53 million] of which 65% was Biotech Sector), Clinigen Group PLC of the United Kingdom (£184.36 million [US$229.59 million] of which 61% was Clinical Trial services), and Bachem Holding AG (208.60 million Swiss Francs [US$207.57 million] of which 84% was Active Pharmaceutical Ingredients).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BB Biotech AG
  Stock Performance Chart for BB Biotech AG
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 57.60
(Figures in Swiss Francs)
1 Week 0.9%   13 Weeks 6.8%  
4 Weeks 7.0%   52 Weeks 22.8%  
BB Biotech AG Key Data:
  Ticker: BION Country: Switzerland
  Exchanges: OTH ZHR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 291,996,000
(Year Ending Jan 2016).
Employees: N/A
  Currency: Swiss Francs Market Cap: 2,920,352,947
  Fiscal Yr Ends: December Shares Outstanding: 50,700,572
  Share Type: Inhaberaktie Closely Held Shares: 3,018,540
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.